cis-2-methylazetidin-3-ol hydrochloride

Catalog No. :
ACGOXC384
CAS No. :
1354352-24-1
Molecular Formula :
C4H10ClNO
Molecular Weight :
123.58

IUPAC Name:(2R,3R)-2-methylazetidin-3-ol hydrochloride

cis-2-methylazetidin-3-ol hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$153.00Login to see priceIn stockInquiry
250mg95%$286.00Login to see priceIn stockInquiry
500mg95%$400.00Login to see priceIn stockInquiry
1g95%$471.00Login to see priceIn stockInquiry
5g95%$1711.00Login to see priceIn stockInquiry
10g95%$2852.00Login to see priceIn stockInquiry
25g95%$5703.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namecis-2-methylazetidin-3-ol hydrochloride
IUPAC Name(2R,3R)-2-methylazetidin-3-ol hydrochloride
MDL No.MFCD31728471
Molecular FormulaC4H10ClNO
Molecular Weight123.58
SMILESO[C@H]1[C@@H](C)NC1.[H]Cl
InChI KeyVGWXJFDIRONLQP-VKKIDBQXSA-N
Synonymrel-(2R,3R)-2-methylazetidin-3-ol hydrochloride;3-Azetidinol, 2-methyl-, hydrochloride (1:1), (2R,3R)-rel-;rel-(2s,3s)-2-methylazetidin-3-ol hydrochloride
CAS No.1354352-24-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACGOXC384 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGOXC384 route product structure diagram
    ACGOXC3841354352-24-1 In Stock
Inquiry

2. ACGOXC384 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCIXG419 route compound structure diagram
    ACCIXG4191638744-75-8 In Stock
  2. Then
  3. ACGOXC384 route product structure diagram
    ACGOXC3841354352-24-1 In Stock
Inquiry

Comments (0)